CEFTOCIDIN Line: Acute Mastitis and Dryness. The backing of an original development with the pride of being the first intramammary product with cephalexin in the veterinary field.
First-choice synergistic antibiotic combination.
01.
Cephalexin plus neomycin incorporated in a rapid-release excipient, allowing high concentrations of antibiotic throughout the interval between doses.
02.
Very low dose of Prednisolone, which reduces the loss of functioning tissue, improves the blood-mammary barrier and is friendly to the gland's defenses.
01.
The concept here is sequential action. Cephalexin is first released over a short period of time, sensitizing staphylococci and streptococci to the action of penicillin, which is slowly released and superlatively effective against the sensitive germ, combined with the effect of neomycin throughout the rest of the drying process.
02.
Its use in cows entering the dry period has a very important curative effect on subclinical mastitis, prevents infections during this period, and minimizes risks in the next lactation.
Healing effect and prophylactic effect.
Injector with flex ring.
The specially developed "flex ring injector," patented by Fundacion Laboratory, prevents damage to the nipple duct, no matter how forceful or abrupt the insertion. It does not scratch or puncture, ensuring the protection of the nipple mucosa.
Presentation
Both products are presented in athermal boxes containing 20 sterile injectors. Each injector is enclosed in an airtight, sterile wrapper. Product irradiated by the National Atomic Energy Commission.
Specie
Bovines